Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
about
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy of daratumumab-based ...... ed outside of clinical trials.
@en
type
label
Efficacy of daratumumab-based ...... ed outside of clinical trials.
@en
prefLabel
Efficacy of daratumumab-based ...... ed outside of clinical trials.
@en
P2093
P2860
P50
P356
P1476
Efficacy of daratumumab-based ...... ed outside of clinical trials.
@en
P2093
Amie L Fonder
Arjun Lakshman
Francis K Buadi
Jithma P Abeykoon
Miriam A Hobbs
Nelson Leung
Prashant Kapoor
Rahma Warsame
Ronald S Go
P2860
P356
10.1002/AJH.24883
P50
P577
2017-08-11T00:00:00Z